AEON Biopharma, Inc. (AEON) - Latest Market Data

Price & Market Data

Price: $0.777

Daily Change: -$0.044 / 5.66%

Daily Range: $0.752 - $0.821

Market Cap: $20,445,964

Daily Volume: 134,780

Performance Metrics

1 Week: 5.22%

1 Month: -25.39%

3 Months: -31.61%

6 Months: 1.99%

1 Year: 61.56%

YTD: -25.39%

About AEON Biopharma, Inc. (AEON)

The definitive guide to AEON Biopharma, Inc. (AEON). Current price: 0.777, daily change: -$0.044 / 5.66%. Market cap: 20,445,964. All performance metrics you need.

Company Details

Employees: 8

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.

Selected stocks

Gogo Inc. (GOGO)

ChowChow Cloud International Holdings Limited (CHOW)

Namib Minerals (NAMM)

GAMCO Global Gold, Natural Resources & Income Trust (GGN)